371 related articles for article (PubMed ID: 36359771)
21. Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas.
Piunti A; Hashizume R; Morgan MA; Bartom ET; Horbinski CM; Marshall SA; Rendleman EJ; Ma Q; Takahashi YH; Woodfin AR; Misharin AV; Abshiru NA; Lulla RR; Saratsis AM; Kelleher NL; James CD; Shilatifard A
Nat Med; 2017 Apr; 23(4):493-500. PubMed ID: 28263307
[TBL] [Abstract][Full Text] [Related]
22. EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas.
Mohammad F; Weissmann S; Leblanc B; Pandey DP; Højfeldt JW; Comet I; Zheng C; Johansen JV; Rapin N; Porse BT; Tvardovskiy A; Jensen ON; Olaciregui NG; Lavarino C; Suñol M; de Torres C; Mora J; Carcaboso AM; Helin K
Nat Med; 2017 Apr; 23(4):483-492. PubMed ID: 28263309
[TBL] [Abstract][Full Text] [Related]
23. Histone deposition pathways determine the chromatin landscapes of H3.1 and H3.3 K27M oncohistones.
Sarthy JF; Meers MP; Janssens DH; Henikoff JG; Feldman H; Paddison PJ; Lockwood CM; Vitanza NA; Olson JM; Ahmad K; Henikoff S
Elife; 2020 Sep; 9():. PubMed ID: 32902381
[TBL] [Abstract][Full Text] [Related]
24. Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27).
McCabe MT; Graves AP; Ganji G; Diaz E; Halsey WS; Jiang Y; Smitheman KN; Ott HM; Pappalardi MB; Allen KE; Chen SB; Della Pietra A; Dul E; Hughes AM; Gilbert SA; Thrall SH; Tummino PJ; Kruger RG; Brandt M; Schwartz B; Creasy CL
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2989-94. PubMed ID: 22323599
[TBL] [Abstract][Full Text] [Related]
25. Dual Regulation of Histone Methylation by mTOR Complexes Controls Glioblastoma Tumor Cell Growth via EZH2 and SAM.
Harachi M; Masui K; Honda H; Muragaki Y; Kawamata T; Cavenee WK; Mischel PS; Shibata N
Mol Cancer Res; 2020 Aug; 18(8):1142-1152. PubMed ID: 32366675
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic-Targeted Treatments for H3K27M-Mutant Midline Gliomas.
Lu VM; Daniels DJ
Adv Exp Med Biol; 2021; 1283():73-84. PubMed ID: 33155139
[TBL] [Abstract][Full Text] [Related]
27. Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation.
Tang G; Guo J; Zhu Y; Huang Z; Liu T; Cai J; Yu L; Wang Z
Int J Oncol; 2018 Jun; 52(6):1899-1911. PubMed ID: 29620187
[TBL] [Abstract][Full Text] [Related]
28. Regulation of histone methylation by automethylation of PRC2.
Wang X; Long Y; Paucek RD; Gooding AR; Lee T; Burdorf RM; Cech TR
Genes Dev; 2019 Oct; 33(19-20):1416-1427. PubMed ID: 31488576
[TBL] [Abstract][Full Text] [Related]
29. Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells.
Li H; Cai Q; Godwin AK; Zhang R
Mol Cancer Res; 2010 Dec; 8(12):1610-8. PubMed ID: 21115743
[TBL] [Abstract][Full Text] [Related]
30. Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications.
Kwon MJ; Kim SS; Choi YL; Jung HS; Balch C; Kim SH; Song YS; Marquez VE; Nephew KP; Shin YK
Carcinogenesis; 2010 Jun; 31(6):974-83. PubMed ID: 20053926
[TBL] [Abstract][Full Text] [Related]
31. Histone Deacetylase 1 (HDAC1) Negatively Regulates Thermogenic Program in Brown Adipocytes via Coordinated Regulation of Histone H3 Lysine 27 (H3K27) Deacetylation and Methylation.
Li F; Wu R; Cui X; Zha L; Yu L; Shi H; Xue B
J Biol Chem; 2016 Feb; 291(9):4523-36. PubMed ID: 26733201
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional alterations in glioma result primarily from DNA methylation-independent mechanisms.
Court F; Le Boiteux E; Fogli A; Müller-Barthélémy M; Vaurs-Barrière C; Chautard E; Pereira B; Biau J; Kemeny JL; Khalil T; Karayan-Tapon L; Verrelle P; Arnaud P
Genome Res; 2019 Oct; 29(10):1605-1621. PubMed ID: 31533980
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic activation of a RAS/MYC axis in H3.3K27M-driven cancer.
Pajovic S; Siddaway R; Bridge T; Sheth J; Rakopoulos P; Kim B; Ryall S; Agnihotri S; Phillips L; Yu M; Li C; Milos S; Patel P; Srikanthan D; Huang A; Hawkins C
Nat Commun; 2020 Dec; 11(1):6216. PubMed ID: 33277484
[TBL] [Abstract][Full Text] [Related]
34. Histone trimethylation of the p53 gene by expression of a constitutively active prolactin receptor in prostate cancer cells.
Tan D; Tan S; Zhang J; Tang P; Huang J; Zhou W; Wu S
Chin J Physiol; 2013 Oct; 56(5):282-90. PubMed ID: 24032713
[TBL] [Abstract][Full Text] [Related]
35. Diffuse midline glioma: review of epigenetics.
Cooney TM; Lubanszky E; Prasad R; Hawkins C; Mueller S
J Neurooncol; 2020 Oct; 150(1):27-34. PubMed ID: 32804378
[TBL] [Abstract][Full Text] [Related]
36. Prognostic role of H3K27M mutation, histone H3K27 methylation status, and EZH2 expression in diffuse spinal cord gliomas.
Ishi Y; Takamiya S; Seki T; Yamazaki K; Hida K; Hatanaka KC; Ishida Y; Oda Y; Tanaka S; Yamaguchi S
Brain Tumor Pathol; 2020 Jul; 37(3):81-88. PubMed ID: 32529280
[TBL] [Abstract][Full Text] [Related]
37. Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma.
Huang TY; Piunti A; Lulla RR; Qi J; Horbinski CM; Tomita T; James CD; Shilatifard A; Saratsis AM
Acta Neuropathol Commun; 2017 Apr; 5(1):28. PubMed ID: 28416018
[TBL] [Abstract][Full Text] [Related]
38. Dysregulation of histone H3 lysine 27 trimethylation in transforming growth factor-β1-induced gene expression in mesangial cells and diabetic kidney.
Jia Y; Reddy MA; Das S; Oh HJ; Abdollahi M; Yuan H; Zhang E; Lanting L; Wang M; Natarajan R
J Biol Chem; 2019 Aug; 294(34):12695-12707. PubMed ID: 31266808
[TBL] [Abstract][Full Text] [Related]
39. EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells.
Cardenas H; Zhao J; Vieth E; Nephew KP; Matei D
Oncotarget; 2016 Dec; 7(51):84453-84467. PubMed ID: 27563817
[TBL] [Abstract][Full Text] [Related]
40. Rpp29 regulates histone H3.3 chromatin assembly through transcriptional mechanisms.
Shastrula PK; Lund PJ; Garcia BA; Janicki SM
J Biol Chem; 2018 Aug; 293(32):12360-12377. PubMed ID: 29921582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]